Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Express Scripts
Moodys
AstraZeneca
Fuji
US Army
Deloitte
UBS
Queensland Health

Generated: August 18, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LITHOBID

« Back to Dashboard

Clinical Trials for LITHOBID

Trial ID Title Status Sponsor Phase Summary
NCT00183443 Treatment of Mania Symptoms With Drug Therapy Completed National Institute of Mental Health (NIMH) Phase 3 This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania.
NCT00183443 Treatment of Mania Symptoms With Drug Therapy Completed Palo Alto Veterans Institute for Research Phase 3 This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania.
NCT00601536 Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions Completed Roxane Laboratories N/A The objective of this study was the bioequivalence of a Roxane lithium carbonate 300 mg extended release tablet formulation compared to Solvay's Lithobid 300 mg extended release tablet under fasting conditions using a single-dose, randomized, 2 treatment, 2-period, 2-sequence crossover design.
NCT00602394 Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions Completed Roxane Laboratories N/A The objective of this study was the bioequivalence of a Roxane lithium carbonate 300 mg extended release tablet formulation compared to Solvay's Lithobid 300 mg extended release tablet under fed conditions using a single-dose, randomized, 2 treatment, 2-period, 2-sequence crossover design.
NCT00627887 Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression Completed Uppsala-Örebro Regional Research Council Phase 4 The purpose of the study is to determine if continuation electroconvulsive therapy (ECT) is safe and effective in relapse prevention of depression.
NCT00627887 Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression Completed Örebro County Council Phase 4 The purpose of the study is to determine if continuation electroconvulsive therapy (ECT) is safe and effective in relapse prevention of depression.
NCT01272531 Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD) Unknown status University of California, San Diego Phase 4 This is a prospective pharmacogenomics study of mood stabilizer response. The goal of this work is to identify genes associated with good response of patients with bipolar disorder to two commonly used mood stabilizing agents, lithium and valproate.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for LITHOBID

Condition Name

Condition Name for LITHOBID
Intervention Trials
Bipolar Disorder 4
Asthma: [Nos] or [Attack] 1
Treatment Resistant Depression 1
Schizophrenia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for LITHOBID
Intervention Trials
Bipolar Disorder 5
Depressive Disorder 3
Depression 3
Disease 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for LITHOBID

Trials by Country

Trials by Country for LITHOBID
Location Trials
United States 14
Sweden 2
Canada 1
Norway 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for LITHOBID
Location Trials
Pennsylvania 2
California 2
Texas 2
Minnesota 1
New Mexico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for LITHOBID

Clinical Trial Phase

Clinical Trial Phase for LITHOBID
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 2 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for LITHOBID
Clinical Trial Phase Trials
Completed 4
Unknown status 1
Enrolling by invitation 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for LITHOBID

Sponsor Name

Sponsor Name for LITHOBID
Sponsor Trials
Roxane Laboratories 2
Risk Benefit Statistics LLC 1
National Institute of Mental Health (NIMH) 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for LITHOBID
Sponsor Trials
Other 13
NIH 2
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Argus Health
Teva
US Army
McKesson
Queensland Health
Accenture
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.